PHAGE 1000 SR TAB is a premium-quality sustained-release oral antidiabetic medication developed to support long-term glycemic control in patients diagnosed with Type 2 Diabetes Mellitus. Each tablet delivers 1000 mg of Metformin Hydrochloride in a sustained-release (SR) formulation, allowing for gradual drug release throughout the day, thereby improving patient compliance and minimizing the risk of gastrointestinal disturbances typically associated with conventional immediate-release formulations.

Metformin, the active pharmaceutical ingredient in PHAGE 1000 SR TAB, is a biguanide-class oral hypoglycemic agent globally recognized as a first-line treatment for non-insulin-dependent diabetes. It functions by reducing hepatic glucose production, improving insulin sensitivity in muscle tissues, and slowing intestinal glucose absorption, thereby aiding in effective blood sugar regulation without causing significant weight gain or hypoglycemia when used as monotherapy.

PHAGE 1000 SR TAB is particularly beneficial for overweight and obese patients with Type 2 diabetes, where insulin resistance plays a major role in disease pathology. The sustained-release matrix embedded in the formulation ensures consistent plasma drug concentrations, which reduces the frequency of dosing to once daily and enhances tolerability. This approach supports long-term therapy and improves adherence in chronic disease management.

Manufactured by Bluepill Express, a trusted name in third-party pharmaceutical production and export, PHAGE 1000 SR TAB is formulated in WHO-GMP, ISO-certified, and regulatory-compliant facilities using premium active ingredients and pharmaceutically approved excipients. Each batch is subjected to strict in-process quality control measures, ensuring high bioavailability, stability, and therapeutic consistency across global markets.

This sustained-release formulation is ideal for patients requiring high-dose Metformin therapy or transitioning from divided immediate-release doses to a simplified once-daily regimen. PHAGE 1000 SR TAB is widely used as a monotherapy or in conjunction with other antidiabetic agents such as sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, or insulin, based on individual patient needs and physician recommendations.

PHAGE 1000 SR TAB is available in high-protection alu-alu packaging or HDPE bottles to maintain stability and shelf life under various climatic conditions. Custom labeling, private branding, multilingual packs, and compliance documentation such as Certificate of Analysis, Batch Manufacturing Records, Stability Data, and Dossiers are provided by Bluepill Express for seamless international registration and distribution.

This formulation is increasingly popular in international markets due to its effectiveness, affordability, and ease of administration. Bluepill Express serves as a reliable partner for global pharmaceutical brands, hospitals, government tenders, and institutional procurement programs aiming to strengthen their diabetic care portfolio.